As of 2026-04-20, the EV/EBITDA ratio of Biodesix, Inc. (BDSX) is -7.26. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Biodesix,'s latest enterprise value is 158.02 mil USD. Biodesix,'s TTM EBITDA according to its financial statements is -21.77 mil USD. Dividing these 2 quantities gives us the above Biodesix, EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.1x - 8.5x | 7.9x |
| Forward P/E multiples | 6.0x - 9.0x | 8.0x |
| Fair Price | (18.61) - (21.61) | (20.50) |
| Upside | -241.6% - -264.5% | -256.0% |
| Date | EV/EBITDA |
| 2026-04-17 | -7.26 |
| 2026-04-16 | -7.34 |
| 2026-04-15 | -7.04 |
| 2026-04-14 | -6.81 |
| 2026-04-13 | -7.36 |
| 2026-04-10 | -7.25 |
| 2026-04-09 | -7.34 |
| 2026-04-08 | -7.76 |
| 2026-04-07 | -7.89 |
| 2026-04-06 | -8.26 |
| 2026-04-02 | -8.13 |
| 2026-04-01 | -7.99 |
| 2026-03-31 | -7.87 |
| 2026-03-30 | -7.55 |
| 2026-03-27 | -7.74 |
| 2026-03-26 | -7.92 |
| 2026-03-25 | -8.17 |
| 2026-03-24 | -8.35 |
| 2026-03-23 | -7.96 |
| 2026-03-20 | -8.04 |
| 2026-03-19 | -8.69 |
| 2026-03-18 | -8.59 |
| 2026-03-17 | -8.82 |
| 2026-03-16 | -9.14 |
| 2026-03-13 | -9.40 |
| 2026-03-12 | -9.98 |
| 2026-03-11 | -9.94 |
| 2026-03-10 | -9.79 |
| 2026-03-09 | -10.09 |
| 2026-03-06 | -9.81 |
| 2026-03-05 | -8.49 |
| 2026-03-04 | -8.24 |
| 2026-03-03 | -8.33 |
| 2026-03-02 | -8.44 |
| 2026-02-27 | -8.25 |
| 2026-02-26 | -7.75 |
| 2026-02-25 | -7.16 |
| 2026-02-24 | -7.20 |
| 2026-02-23 | -7.09 |
| 2026-02-20 | -7.28 |
| 2026-02-19 | -7.08 |
| 2026-02-18 | -7.00 |
| 2026-02-17 | -7.10 |
| 2026-02-13 | -6.49 |
| 2026-02-12 | -6.21 |
| 2026-02-11 | -5.99 |
| 2026-02-10 | -6.02 |
| 2026-02-09 | -5.80 |
| 2026-02-06 | -6.01 |
| 2026-02-05 | -5.82 |